Diagnostic use of antibodies against aquaporin water channel proteins and PAX-2, a nuclear transcription factor in renal development, was tested in 202 renal neoplasms, using tissue microarray technique. Immunohistochemistry for aquaporin-1, aquaporin-2, PAX-2, CD10, and cytokeratin 7 was performed on 102 clear cell renal cell carcinomas, 44 papillary renal cell carcinomas (among them 34 type 1 and 10 type 2), 24 chromophobe renal cell carcinomas, three collecting duct carcinomas (carcinomas of the collecting ducts of Bellini), and 29 oncocytomas. Aquaporin-1 expression was found in clear cell renal cell carcinomas and papillary renal cell carcinomas of both types (78 and 73%, respectively), but not in chromophobe renal cell carcinomas, collecting duct carcinomas, and oncocytomas. Aquaporin-2 expression was not seen in any of the tested tumors. PAX-2 and CD10 was found in the majority of clear cell renal cell carcinomas (88 and 85%, respectively) but only in few papillary renal cell carcinomas, chromophobe renal cell carcinomas and oncocytomas. Decrease or loss of aquaporin-1 and PAX-2 was shown in higher grades compared to lower grades of clear cell renal cell carcinomas (Po0.0001 and o0.0245, respectively). Cytokeratin 7 was rarely seen in clear cell renal cell carcinomas, type 2 papillary renal cell carcinomas, and oncocytomas, but was found in the majority of type 1 papillary renal cell carcinomas (97.1%) and chromophobe renal cell carcinomas (88%). Aquaporin-1 and PAX-2 expression was found to correlate with nuclear grading for clear cell renal cell carcinomas but not for papillary renal cell carcinomas. No correlation of tumor stage and aquaporin-1 and PAX-2 expression was seen. Aquaporin-1 and PAX-2 are reliable markers for clear cell renal cell carcinomas of lower grades but not for higher grades. CD10 expression remains stable, independent of nuclear grading.
We tested the potential diagnostic use of antibodies against aquaporins, water channel proteins found in different segments of the renal tubulary system, [1] [2] [3] and PAX-2 a member of the paired box family and nuclear transcription factor in development of renal epithelia. 4 The expression of these antigens was analyzed in different types of renal tumors. Aquaporin-1, aquaporin-2 and PAX-2 were compared to two established antibodies, CD10 and cytokeratin 7, which are in use in renal tumor pathology. Decrease or loss of these antigens depending on tumor grading and pT staging was assessed, to get information on the diagnostic reliability of different markers, depending on tumor differentiation. Renal neoplasms comprise several kinds of different tumors. In most cases it is possible to distinguish different types of renal neoplasms on the basis of conventionally stained tissue sections, alone. However, overlapping morphological characteristics can sometimes pose difficulties to make a proper diagnosis. Diagnostic problems can eventually arise in discriminating tumors like some chromophobe renal cell carcinomas, oncocytomas, and the granular variant of clear cell renal cell carcinoma. [5] [6] [7] As different types of renal neoplasms have different prognosis, many immunohistochemical markers have been tested to support a correct histological diagnostic decision. In this study, we examined 202 renal neoplasms, including renal cell carcinomas, as well as oncocytomas, using immunohistochemistry and tissue microarray technology which is a useful tool for efficient and rapid analysis of protein expression by immunohistochemistry.
Materials and methods

Patients
The study included 202 paraffin-embedded tumors from the archives of the Department of Clinical Pathology, Medical University of Vienna. Specimens were all sliced before they were routinely fixed overnight with 4.5% buffered formaldehyde. The group of renal cell carcinomas included exclusively primary tumors: 102 of clear cell, 44 of papillary (34 type 1 and 10 type 2), 24 of chromophobe, and three of collecting duct type (carcinoma of the collecting ducts of Bellini). Benign renal tumors included 29 oncocytomas. All tumors were re-evaluated. Carcinomas were classified according to the recommendations of the WHO Classification 2004, 11 staged according to the TNM-System, 12 and graded according to Fuhrman et al. 13 Papillary carcinomas were separated in type 1 and type 2, according to Delahunt and Eble. 14 None of the patients had been treated with chemotherapy prior to surgery. Pathological grading and staging of renal carcinomas is summarized in Table 1 .
Construction of Tissue Microarrays
Hematoxylin-and eosin-stained slides of all tumors were reviewed and representative areas were selected. These were areas with characteristic histomorphology of the individual tumor, including the highest grade. In Grade 4 tumors areas with spindle-shaped cells were seen in different amounts between 5 and 75%. True sarcoma areas were not found. A total of 606 tumor tissue cylinders with a diameter of 0.6 mm were punched out from those regions of the corresponding paraffin blocks. From each tumor, three tissue cylinders were taken. Additionally, nine punches of regular tissues, including renal cortex, renal medullary tissue, and pelvic urothelium from tumor-free renal parenchyma were collected. All tissue cylinders were precisely arrayed in receptor paraffin blocks, using a tissue microarrayer system (Beecham s , CA, USA). The last six positions at the right corner of the tissue microarrays were left free to enable correct orientation of the sections. In addition to immunohistochemical evaluation, histology of all sections was reviewed, to ensure that the sample of deeper portions of the tumor cores remained representative.
Immunohistochemistry
Sections, 4-mm thick, were cut from the tissue microarrays and transferred to silanized glass slides. Sections were stained with hematoxylin and eosin and with antibodies listed in Table 2 . Signal detection was performed with the avidin-biotin reaction, using peroxidase, except in cytokeratin 7 staining, where alkaline phosphatase was used. Antigen retrieval for cytokeratin 7 was performed by microwave pretreatment in citrate buffer (pH 6.0) for 10 min with 450 W, and for CD10 by autoclave pretreatment for 10 min with 450 W. For aquaporin-1, aquaporin-2, and PAX-2 this was done by microwave pretreatment for 20 min at 120 W, and 3 Â 5 min each at 450 W. 15 
Scoring and Statistical Analysis
Sections were scored using a semiquantitative scale for each individual tumor tissue cylinder on the array slide, with -for negative staining, þ for focal staining (o10% of cells showing immunoreac tivity), þ þ for staining of 10-50% of tumor cells, þ þ þ for diffuse staining (450% of cells showing immunoreactivity), and 0 for uninterpretable Table 1 Grading and staging of renal cell carcinomas 
Results
Immunohistochemical Results in Normal Renal Parenchyma
In the nine tissue cores with normal renal parenchyma included in the microarrays, strong membranous aquaporin-1 staining was seen in the epithelia of all proximal renal tubules, in the descending limb of Henle, in glomerular endothelial cells, and extraglomerular capillaries. Aquaporin-2 was detected in the epithelia of collecting ducts. PAX-2 expression could not be detected in normal renal parenchyma. CD10 antigen was shown in the epithelia of all proximal tubules and in glomerular epithelial cells. Cytokeratin 7 was expressed in the epithelia of distal tubules, collecting ducts, and urothelial cells of the renal pelvis.
Immunohistochemical Results in Renal Neoplasms
Aquaporin-1 scoring results Aquaporin-1 expression was seen in the majority of all renal cell carcinomas, but only in one single case (3.5%) of renal oncocytomas. This tumor with characteristic oncocytic histology demonstrated prominent diffuse membranous staining. All other oncocytomas were completely negative. In the carcinoma group, clear cell renal cell carcinomas and papillary renal cell carcinomas demonstrated membranous expression of aquaporin-1 in 78 and 73%, respectively. No significant difference was found comparing type 1 and type 2 papillary renal cell carcinomas. Chromophobe renal cell carcinomas and collecting duct carcinomas were negative.
Aquaporin-2 scoring results
Aquaporin-2 was not detected in any of the examined renal neoplasms.
PAX-2 scoring results
Nuclear staining of PAX-2 transcription factor was seen in the majority of renal cell carcinomas, and in 14% of renal oncocytomas, including the case of oncocytoma with aquaporin-1 expression. In the carcinoma group, clear cell renal cell carcinomas demonstrated expression of PAX-2 in 88%. It was also detected in 18% of papillary renal cell carcinomas, 13% of chromophobe renal cell carcinomas, and not in collecting duct carcinomas. No significant difference was found comparing type 1 and type 2 papillary renal cell carcinomas.
CD10 scoring results
Expression of CD10 antigen was seen in the majority of renal cell carcinomas, but only in one case (3.5%) of renal oncocytomas. This was the same oncocytoma which showed also aquaporin-1 and PAX-2 expression. In the carcinoma group, clear cell renal cell carcinomas demonstrated expression of CD10 antigen in 85%, papillary renal cell carcinomas in 23%, and chromophobe renal cell carcinomas in only 4%. Collecting duct carcinomas were negative.
Cytokeratin 7 scoring results
Cytokeratin 7 was seen in 39% of all renal cell carcinomas, and in 7% of renal oncocytomas. In the carcinoma group, clear cell renal cell carcinomas demonstrated expression of cytokeratin 7 in only 8%, but in 77% of all papillary renal cell carcinomas (97% type 1, 30% type 2), 88% of chromophobe renal cell carcinomas, and in one of three collecting duct carcinomas. Table 3 and Figure 1 summarize the immunohistochemical results.
Influence of Tumor Grading on Expression Profile in Renal Cell Carcinomas
Comparing immunohistochemical results with grading within specific subtypes of carcinomas, significant differences were seen in clear cell renal cell carcinomas, with decrease or loss of aquaporin-1 and PAX-2 correlating with increasing nuclear grades (Po0.0001 and o0.0245, respectively). For papillary renal cell carcinomas, a decrease of aquaporin-1 was noted with increasing grading, however, this difference was not statistically significant. CD10 expression did not show correlation with tumor grading.
Influence of Tumor Staging (pT) on Expression Profile in Renal Cell Carcinomas
Comparing immunohistochemical results of carcinomas with different pT stages within the specific tumor groups, we did not find significant correlations with the studied markers.
Discussion
Aquaporins are water-transporting proteins, expressed in many epithelial tissues and endothelium 3 and in some urinary tract neoplasms. [15] [16] [17] In the normal kidney, aquaporin-1 is only expressed in epithelial cells of proximal tubules and in the Aquaporin-1 and PAX-2 in renal neoplasms PR Mazal et al descending limb of Henle, but not in other nephron segments, collecting ducts or urothelial cells, whereas aquaporin-2 is selectively expressed in collecting ducts. 1, 2 Only two studies of aquaporin-1 and aquaporin-2 in small series of renal cell carcinomas have been published in the literature. 16, 17 However, these studies are based primarily on Northern blot analysis and in situ hybridization, and no classification of renal carcinomas with subtypes was done. Therefore, we tested the diagnostic utility of aquaporin-1 and -2 on paraffin-embedded tissue of common types of renal cell carcinomas and renal oncocytomas. We found prominent expression of aquaporin-1 in clear cell renal cell carcinomas and papillary renal cell carcinomas, but not in chromophobe renal cell carcinomas or in collecting duct carcinomas. These results support the widely accepted histogenetic concept of the origin of clear cell renal cell carcinoma and papillary renal cell carcinoma from the proximal part of the nephron, and the origin of chromophobe carcinoma and renal oncocytoma from intercalated cells in collecting tubules. 18 Aquaporin-1 expression decreased significantly in higher grades of clear cell renal cell carcinoma, compared to lower grades of this tumor group. This was seen in clear cell renal cell carcinomas but not in papillary renal cell carcinomas. Oncocytomas were usually negative. Aquaporin-2 was not expressed in our series, including three collecting duct carcinomas.
PAX-2 belongs to a family of transcription factors. It is required for development and proliferation of renal tubules. PAX-2 expression is downregulated in mature tissue, and usually no expression is seen in the healthy, adult kidney. 4 In one recent study, 56 renal tumors were analyzed by frozentissue immunohistochemistry. 19 In this study, Daniel et al demonstrated expression of PAX-2 in more than 90% of 33 clear cell renal cell carcinomas and in 100% of 12 papillary renal cell carcinomas. They also demonstrated some reactivity in chromophobe renal cell carcinomas and oncocytomas. Our study is the first, testing PAX-2 expression in a large number of paraffinembedded renal tumors. Our results are similar, demonstrating PAX-2 expression in 88% of clear cell renal cell carcinomas, and reactivity in some chromophobe renal cell carcinomas and oncocytomas. However, expression of PAX-2 in papillary renal cell carcinomas was significantly lower with 18% of papillary renal cell carcinomas in our series, compared to 100% in Daniels frozen sections. We have no explanation for this discrepancy, but emphasize on the fact that comparing immunohistochemical results from frozen tissue with those from paraffin tissue may be difficult with some antibodies.
Regarding correlation of PAX-2 and tumor grading, we observed a significant decrease of PAX-2 expression in higher grades of clear cell renal cell carcinomas compared to lower grades. This was seen in clear cell renal cell carcinomas, but not in papillary renal cell carcinomas.
Our results regarding CD10 and cytokeratin 7 are in accordance with those of Kim and Kim, 6 and Avery et al, 20 reporting, that the majority of CD10-positive renal tumors are clear cell renal cell carcinomas and papillary renal cell carcinomas. Kim and Kim 6 and Delahunt and Eble 14 demonstrated that type-1 papillary renal cell carcinomas and chromophobe renal cell carcinomas express cytokeratin 7, whereas clear cell renal cell carcinomas and oncocytomas are usually negative, which was also found in our study. Cytokeratin 7 can therefore be a useful marker for the differentiation of chromophobe renal cell carcinomas and oncocytomas. Regarding correlation of CD10 and cytokeratin 7, and tumor grading, no significant differences were observed.
In conclusion, we found significant expression of aquaporin-1 in clear cell renal cell carcinomas and papillary renal cell carcinomas but typically not in chromophobe renal cell carcinomas and in oncocytomas. Aquaporin-2 was not detected in renal carcinomas and oncocytomas. PAX-2 and CD-10 expression was found in the majority of clear cell renal cell carcinomas. No significant correlation of pT stage with aquaporin-1 or PAX-2 expression could be demonstrated. Clear cell renal cell carcinomas with higher grades showed a significant decrease or loss of aquaporin-1 and PAX-2 compared to lower grades in clear cell renal cell carcinomas. Higher grades in papillary renal cell carcinomas did not.
Aquaporin-1 and PAX-2 are reliable markers for clear cell renal cell carcinomas of lower grades but not for higher grades, whereas CD10 expression remains stable with no significant differences comparing nuclear grades.
